Methylphenidate is a stimulant drug that doctors prescribe to treat attention deficit hyperactivity disorder (ADHD) and narcolepsy. Learn about how it works, its side effects, and typical dosages ...

Methylphenidate Extended-Release prescription and dosage information for physicians and health care professionals. Pharmacology, adverse reactions, warnings, and Methylphenidate Extended ...

The drugs modafinil and methylphenidate have been shown to significantly improve the performance of chess players, though there are also some negative effects. Business Insider Subscribe Newsletters ...

Methylphenidate Chewable prescription and dosage information for physicians and health care professionals. Pharmacology, adverse reactions, warnings, and Methylphenidate Chewableside effects.

Hundreds of thousands of Australians who use a certain type of ADHD medication will be forced to use amphetamine-based ...

The prescription use of the stimulants methylphenidate and amphetamine for the treatment of attention deficit–hyperactivity disorder (ADHD) has been increasing. In 2007, the Food and Drug ...

In a large head-to-head trial, the response rate for methylphenidate (56%) was superior to that of atomoxetine (45%) for children and teens with ADHD.

Methylphenidate mainly affected activation in the frontal lobes during inhibitory control tasks. During selective attention tasks, a wider range of brain areas were affected.

Methylphenidate appears to be the best first-line drug choice for attention- deficit/hyperactivity disorder (ADHD) in children and adolescents, new research shows.

Youth with attention deficit hyperactivity disorder (ADHD) have deficits in interference inhibition, which can be improved with the indirect catecholamine agonist methylphenidate (MPH). Functional ...

Stimulant drugs, including D-amphetamine, cocaine, and methylphenidate, increase cigarette smoking in controlled human laboratory experiments. Although the mechanism(s) underlying this effect are ...

To date, 13 trials 15-27 have evaluated methylphenidate versus placebo for the treatment of CRF, of which only five enrolled 100 or more participants. 15,20,22,24,27 The characteristics of the ...